Ignite Creation Date:
2025-12-25 @ 1:37 AM
Ignite Modification Date:
2026-02-27 @ 10:34 AM
Study NCT ID:
NCT06686394
Status:
RECRUITING
Last Update Posted:
2025-12-24
First Post:
2024-11-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-02-26
Start Date Type:
ACTUAL
Primary Completion Date:
2030-04-18
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-04-18
Completion Date Type:
ESTIMATED
First Submit Date:
2024-11-11
First Submit QC Date:
None
Study First Post Date:
2024-11-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-23
Last Update Post Date:
2025-12-24
Last Update Post Date Type:
ACTUAL